Alexandria Venture Investments, LLC

Insider Reports History

Entity
Company
Location
26 North Euclid Avenue, Pasadena, CA
Signature
By: ALEXANDRIA REAL ESTATE EQUITIES, INC., a Maryland corporation, managing member By: /s/ Dean A. Shigenaga Chief Financial Officer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Alexandria Venture Investments, LLC:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Singular Genomics Systems, Inc. 10%+ Owner Common stock 2.65M $1.12M $0.42 Jun 1, 2021 Direct
Vigil Neuroscience, Inc. 10%+ Owner Common stock 193K $724K $3.75 Jan 11, 2022 Direct
Xilio Therapeutics, Inc. 10%+ Owner Common stock 166K $138K $0.83 Oct 26, 2021 Direct
Singular Genomics Systems, Inc. 10%+ Owner Series A convertible preferred stock 0 Jun 1, 2021 Direct
Singular Genomics Systems, Inc. 10%+ Owner Series B convertible preferred stock 0 Jun 1, 2021 Direct
Vigil Neuroscience, Inc. 10%+ Owner Series A convertible preferred stock 0 Jan 11, 2022 Direct
Vigil Neuroscience, Inc. 10%+ Owner Series B convertible preferred stock 0 Jan 11, 2022 Direct
Xilio Therapeutics, Inc. 10%+ Owner Series B convertible preferred stock 0 Oct 26, 2021 Direct

Insider Reports Filed by Alexandria Venture Investments, LLC

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIGL Vigil Neuroscience, Inc. Jan 11, 2022 3 $0 4 Jan 11, 2022 10%+ Owner
VIGL Vigil Neuroscience, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 26, 2021 2 $0 4 Oct 26, 2021 10%+ Owner
XLO Xilio Therapeutics, Inc. Oct 21, 2021 0 $0 3 Oct 21, 2021 10%+ Owner
OMIC Singular Genomics Systems, Inc. Jun 1, 2021 3 $0 4 Jun 1, 2021 10%+ Owner
OMIC Singular Genomics Systems, Inc. May 26, 2021 0 $0 3 May 26, 2021 10%+ Owner